List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 973 studies with search of:   "Docetaxel"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma
Condition: Ovarian Cancer
Interventions: Drug: Docetaxel;   Drug: Carboplatin;   Drug: Docetaxel;   Drug: Liposomal doxorubicin
2 Recruiting Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Vinorelbine;   Drug: Cisplatin;   Drug: Bevacizumab;   Drug: Docetaxel;   Drug: Gemcitabine;   Drug: Bevacizumab;   Drug: Docetaxel;   Drug: Cisplatin;   Drug: Bevacizumab
3 Completed Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Capecitabine;   Drug: Epirubicin;   Drug: Docetaxel
4 Completed Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: Topotecan/Docetaxel combination;   Drug: Docetaxel
5 Recruiting Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Epirubicin;   Drug: Epirubicin;   Drug: Docetaxel
6 Recruiting Study of Docetaxel/Gemcitabine Followed by Chemo-Radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Docetaxel;   Drug: Gemcitabine;   Drug: Carboplatin;   Radiation: Chemoradiotherapy;   Drug: Docetaxel
7 Recruiting Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: Docetaxel;   Drug: cetuximab and docetaxel;   Drug: Pemetrexed;   Drug: Cetuximab & Pemetrexed
8 Active, not recruiting Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Docetaxel;   Drug: Docetaxel
9 Recruiting Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Cancer
Interventions: Drug: docetaxel;   Drug: NPI-2358 + docetaxel
10 Active, not recruiting Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer
Conditions: Breast Neoplasms;   Adjuvant;   Chemotherapy
Interventions: Drug: Docetaxel, Doxorubicin or Epirubicin, Cyclophosphamide;   Drug: Docetaxel, Doxorubicin or Epirubicin, Cyclophosphamide
11 Recruiting Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
Condition: Metastatic Gastric or GEJ Cancer
Interventions: Drug: Docetaxel + oxaliplatin;   Drug: Docetaxel + oxaliplatin + cetuximab
12 Active, not recruiting Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)
Condition: Lung Neoplasms
Interventions: Drug: docetaxel and cisplatin followed by concurrent chemoradiotherapy with docetaxel and cisplatin + radiotherapy;   Drug: docetaxel and cisplatin + radiotherapy followed by docetaxel and cisplatin
13 Recruiting A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
Condition: Hormone Refractory Prostate Cancer
Interventions: Drug: AT-101, prednisone and docetaxel;   Drug: placebo, prednisone and docetaxel
14 Recruiting Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: Epirubicin, cyclophosphamide and docetaxel;   Drug: docetaxel, cyclophosphamide
15 Completed Docetaxel in Non Small Cell Lung Cancer (NSCLC)
Condition: Lung Neoplasms
Interventions: Drug: Docetaxel + carboplatin + radiotherapy + docetaxel + gemcitabine;   Other: Docetaxel + gemcitabine + carboplatin + radiotherapy
16 Terminated Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Docetaxel plus doxercalciferol;   Drug: Docetaxel plus placebo
17 Completed Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Docetaxel;   Drug: Docetaxel;   Drug: Docetaxel;   Drug: Docetaxel
18 Recruiting Trial of Partial Breast Irradiation With Various Concurrent Chemotherapy Regimens
Condition: Breast Cancer
Interventions: Other: Standard Dose Dense Doxorubucin and Cyclophosphomide;   Other: Standard Doxorubucin and Cyclophosphomide;   Other: Standard Docetaxel, Carboplatin, and Herceptin;   Other: Standard Docetaxel, Doxorubucin and Cyclophosphomide;   Other: Standard Docetaxel and Cyclophosphomide
19 Terminated A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer
Conditions: Lung Cancer;   Non-Small Cell Lung Cancer
Interventions: Drug: ABT-751;   Drug: Placebo;   Drug: Docetaxel
20 Withdrawn A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: docetaxel;   Drug: CP-868,596 + docetaxel;   Drug: AG-013736 + docetaxel;   Drug: CP-868,596 + AG-013736 + docetaxel

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services